Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year.
Raymond James Maintains Outperform on Dine Brands Global, Lowers Price Target to $85
Raymond James analyst Brian Vaccaro maintains Dine Brands Global (NYSE:DIN) with a Outperform and lowers the price target from $95 to $85.
